Financial Strategies Group’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-35,712
Closed -$587K 102
2026
Q1
$587K Buy
35,712
+118
+0.3% +$1.85K 0.1% 72
2025
Q4
$547K Buy
35,594
+140
+0.4% +$1.98K 0.1% 71
2025
Q3
$476K Buy
35,454
+8,402
+31% +$112K 0.09% 71
2025
Q2
$399K Buy
27,052
+6,026
+29% +$94K 0.08% 77
2025
Q1
$343K Buy
21,026
+6,288
+43% +$116K 0.08% 77
2024
Q4
$269K Sell
14,738
-5,138
-26% -$99.1K 0.06% 90
2024
Q3
$363K Buy
19,876
+3,597
+22% +$68.9K 0.09% 76
2024
Q2
$312K Buy
+16,279
New +$278K 0.08% 72

Other funds holding SEM

Financial Strategies Group's SEM Position: Q2 2026 in Review

Financial Strategies Group sold out of Select Medical (SEM) in Q2 2026, closing a stake of 35,712 shares — an estimated $587K sold.

Financial Strategies Group first reported a position in SEM in Q2 2024 and held it in 8 quarters. The position peaked at $587K in Q1 2026. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Financial Strategies Group reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
  • Financial Strategies Group sold 35,712 Select Medical shares in Q2 2026, an estimated $587K.
  • Financial Strategies Group first reported a position in Select Medical in Q2 2024 and held it in 8 quarters.
  • Financial Strategies Group's Select Medical position peaked at $587K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Financial Strategies Group's 13F filing for Q2 2026, filed 11 Aug 2026.